A potentially significant catalyst to SAC’s share price performance will be the release of an updated Malku Khota preliminary economic assessment…
The drop in share price reflects nervous markets and understandably cautious customers, which have affected growth in the first four months of 2012. The…
Stratec’s new guidance shows uncertainties over 2012 associated with the ongoing Gen-Probe acquisition by Hologic; the FDA has approved the Panther…
IMS confirmation of robust London trading may not surprise, given continuing upbeat market news, but is no less welcome. Not only was group RevPAR gain…
Ormonde’s flagship Barruecopardo tungsten project is slated for first production in 2013 and is forecast to become one of the largest suppliers of…
Positive metallurgical results from Amur’s work on the Kun-Manie project indicate very favourable increases in potential life of mine concentrate…
Cyan has received its largest order to date in the Indian market, worth over $1m. The order provides an endorsement of Cyan’s CyLec technology, and…
In relatively short order, PVE has built a portfolio of assets across the Po Valley region of northern Italy that could quickly exploit the current opportunities…
A lack of available shotcrete equipment and difficult ground conditions in Q112 combined to force changes to the mining sequence, which adversely affected…
Ubisense’s Real-Time Location Systems (RTLS) division has developed a wireless technology for tracking moving assets with a high degree of accuracy.…
Vitec’s more focused approach to its key core markets delivered strong (24%) underlying PBT growth in FY11. Driven by a broadened portfolio across…
Zetar’s year-end trading update confirms the picture outlined in March, with retailers having under-ordered Easter confectionery product. We maintained…
DDD has announced that cumulative TriDef 3D shipments have crossed the 1m mark for both PCs and mobile handsets, underlining the broadening adoption of…
Having exercised its option to co-promote Alpharadin, Algeta is set to enter the commercialisation process with Bayer on a 50/50 basis in the US. The project…
LentiVector’s favourable safety profile is further supported by clinical data presented at ARVO 2012 from the ocular programmes. To date no adverse…
4SC remains focused on finding an ex-Japan partner for resminostat, the oral pan-HDAC inhibitor that could – funding permitting – enter a Phase…
United Drug is proving itself to be robust in spite of the tough austerity measures affecting its key Ireland/UK wholesaling markets, as its smaller but…
The FDA’s requirement for additional analyses of the existing Aorfix dataset in the PMA process means that the clock on the 180-day review will be…
Though breaking a run of seven straight quarters of increasing gold production at Blanket, Caledonia’s Q112 results are still in line with expectations…
The grant of two new patents broadens Phylogica’s core IP portfolio and strengthens its potential to exploit its Phylomer peptide drug discovery…
Sucampo’s stock is up 70% year to date as awareness and expectations rise ahead of a potentially transformational event. The International Court…
Three major motor dealership groups announcing trading updates on the same morning provided a consistent message – conditions are challenging, but…
Beazley has made a positive start to the year. Compared with last year, the claims environment has been benign for industry natural catastrophe events…
After the proposed return of value to shareholders, which we expect to take place later this summer (10p/share), the future of SeaEnergy will depend on…
MCB Finance Group’s Q112 results confirm strong growth with credit issued up 79%, revenue up 65% and a bond issue securing funding for three years.…
KBC’s IMS reports a solid start to the year despite tough market conditions in Europe. Management reiterates its confidence in meeting full-year…
Positive top line results from the first four trials in the IGNITE Phase III programme for QVA149, and clarity on US regulatory filing timelines for NVA237…
Avon’s interims were solid if unspectacular, affected by the timing of certain filter contracts and the non-recurrence of the same level of international…
BB Biotech (BION) invests globally in companies active in the biotechnology sector. Over the last six months, biotech has been one of the best performing…
Aveo’s stock is some 30% off its January levels as investor doubts have crept in during the run-up to an important Phase III presentation at ASCO.…
All of Carador Income Fund’s (CIFU) invested assets are backed by secured US corporate credit, a deliberate decision by the manager to avoid European…
Psion’s IMS states that trading in Q1 has been broadly in line with expectations. Market conditions remain tough but there are signs that Psion is…
Is Private Equity (ISGSY) is a leading private equity firm in Turkey with 13 investments made since 2000 and eight exits successfully completed as of March…
In what was a challenging year for investment banks around the world, IS Yatirim Menkul Degerler (ISY) saw its PBT decline 12% to TRY98.9m as operating…
The Q1 IMS confirms a good start, with progress in both like-for-like sales and new centre openings, a resilient performance in challenging market conditions.…
The Q1 IMS reports group revenue is up 15%, driven by the dominant US business (up 15%, or up 14% in dollar terms vs industry revenues up 6%). Trading…
Counterintuitively for a company serving the hospitality and retail sectors, Churchill China shows continued resilience to constraints in consumer spending.…
Ultra Electronics has yet again demonstrated that the power of the business lies in the management approach and the business model to identify areas of…
BioInvent’s successful rights issue raised SEK104.8m at SEK15.6 per share. The funding gives sufficient cash until Q413 before projected deal upfront…
FY12 had revenue of £11.12m, up 5% on a like for like basis. We project an FY12 adjusted PBT of £906k. Development of the 40-50 core test menu…
It is remarkable when any mining company manages to complete construction under budget and with only slight delays, but Central Asia Metals (CAML) has…
Despite caution on the larger economy, Communisis is pleased with Q1 trading and confident about the rest of the year, based on benefits from good order…
The boards of Omega and Canopius have reached an agreement on the terms of a recommended cash offer at 67p, valuing Omega at approximately £163.9m…
The recent sharp fall in the share price reflects concerns over the lack of firm news on the refinancing of an £83m debt facility due to mature this…
Hambledon’s Q112 activities reported a quarter of “mixed fortunes”, with Q1 gold production of 4,870oz leading to an adjusted 2012 production…
It is a small step at a still early stage, but the beginning of commercial production by one of EnWave’s customers proves that the company’s…
A slippage in the timing of product launches from Q2 to Q3, exacerbated by weak consumer confidence led to a 23% drop in revenues during H112 (ending 31…
In an update released in conjunction with its AGM, StatPro reports that trading in Q112 has been in line with expectations. StatPro now has 80 clients…
Bespak’s first proprietary integrated dose counter (IDC220), incorporated into Teva’s QNASL nasal aerosol, has been FDA approved. IDC220 is…
Waterlogic’s claim that its consumer unit can make water from the Ganges safe and drinkable captures for us the huge potential of its technology.…
Starwood has endorsed growing industry confidence with better than expected Q1 results and reiteration that 2012 may well continue to surprise (EBITDA…
African Barrick Gold’s (ABG) Q1 results were broadly in line with our forecasts, with the exception of unit working costs which were 9.2% lower than…
An independent report confirming a significant upgrade in resources at its flagship Sampaguita gas field has had a dramatic impact on Forum Energy’s…
Imperial Innovations continues to mature its portfolio of existing businesses while expanding its net to seek further investment opportunities in other…
Share plc has announced its Q112 revenue market share was 6.46% (against 6.1% for Q111). While this gain is encouraging, market conditions have been tough…
Greenwich Loan Income Fund (GLIF) has announced its Q112 NAV (47.8p vs 48.3p end December), which has fallen modestly with a 3% adverse dollar/sterling…
“This is not the end. It is not even the beginning of the end. But it is, perhaps, the end of the beginning.” The words of Sir Winston Churchill…
A positive IMS noted that Q1 trading was profitable and in line with management’s expectations. While still early in the year, the group looks on…
The gold price has increased by 11% over the past 12 months but is now 20% below its high and has shown greater volatility in recent months. The rise over…
On 25 April Regency released its maiden JORC compliant resource estimate for the 50% owned Mambare nickel laterite project in Papua New Guinea. The announced…
Park Group has announced the latest product extension to its Love2reward suite, flexecodes, based on its fast growing and innovative flexecash prepaid…
Zeltia’s Pharma Mar subsidiary has received a second $25m milestone payment from Yondelis (trabectedin) ex-Europe partner Janssen (J&J). This follows…
Last year saw good operational progress, but also delays in progressing contracts and in payments. No new contracts were signed. Motive is confident about…
In the 21st century reorganisation of African mining assets, Mwana has assembled a unique portfolio comprising two old warhorses in Zimbabwe combined with…
GKN is a stalwart of the auto and aero sectors. It performed well in 2011, despite disruptions, and should continue to do so, as confirmed by Q112. Well…
2011’s record €241m revenues showed that Manz is no longer dependent on the fortunes of the European or even the global solar market, but can…
Carr’s Milling Industries’ innovations such as Crystalyx feed-blocks and the AminoMax process for more efficient utilisation of protein in…
Dillistone produced a highly respectable performance in FY11 despite the weak backdrop, with revenues and profits ahead of our expectations. Voyager, acquired…
Comptel’s Q1 sales performance suggests its revised sales structure and focus on building service sales are bearing fruit. Licensing sales were below…
IQE again showed its ability to flex its model to retain profitability in 2011. Significant investments in capacity depress near-term cash flows, but our…
Park has issued a trading update on its full year results (to 31 March 2012), due for release on 12 June 2012. The progress that could be seen in key performance…
Next Fifteen’s interim results showed good revenue growth of 11%, with adjusted pre-tax up 15% and EPS up 12%. As anticipated, digital marketing…
Cytec’s Q1 demonstrated that 2012 got off to a good start, with progress being made across large swathes of the business and guidance increased for…
The £1.5m raised by Deltex provides additional working capital given the 40% rise in NHS orders experienced in Q1. NHS hospitals are under significant…
Eckoh expects to report in line FY12 results. The company continues to invest to drive revenue growth and we reduce our FY13 EPS forecast by 10% to reflect…
ACM is coming through the tough trading climate for shipping, very much on course. Profits are running below those of earlier years, but trading volumes…
If the FPH equity story had revolved around site relocations and a new franking machine, investors would be forgiven for categorising the company as a…
2011 saw the benefits of the restructuring exercise that left Masterflex a focused player in high-tech hoses and connectors allowing a twin growth strategy…
A reassuring IMS from Xaar shows Q1 sales and gross margins tracking to expectations. While it is still early in the year, Xaar looks well on track to…
PHP’s IMS (2012 to date) confirmed that banking facilities have been refinanced, which puts funds in place for acquisition-led portfolio growth.…
Vernalis’ three-tier business strategy (commercial, development, research) has been subtly refined following the closure of its recent £65.9m…
Production from Victoria Oil & Gas’s (VOG) flagship Logbaba development in Cameroon is yet to kick off in earnest. However, with installation of…
Aspermont’s strategy of becoming a multi-platform B2B media group serving the global resources industry is producing strong results. This should…
A deal with Merck & Co for the anticancer agent vintafolide has doubled Endocyte’s cash balance and effectively underwritten its lead asset. A US…
Underlying Q2 revenue trends were better than expected in January; subscriptions kept forging ahead and advertising was not as weak as anticipated. There…
Augean has continued its development of a range of solutions to treat and manage a variety of waste streams with the announcement that has entered into…
Walker Greenbank continues to deliver impressive returns, despite the continuing challenge in UK consumer markets. Management’s strategy of sustaining…
On Tuesday 3 April (as near as makes no difference to its target of end-Q1), African Barrick announced a 173koz maiden resource at Kilimani plus a 348koz…
Seeing Machines has announced the appointment of Terry Winters as non-executive chairman. We view the news as a strong positive for the company given Mr…
International Biotechnology Trust’s (IBT) quoted portfolio has, for the past three years, outperformed the NASDAQ Biotechnology Index. Although the…
DDD’s FY11 normalised pre-tax profit came in $0.5m, $0.2m higher than our estimate, on revenues of $5.5m as foreshadowed in February. H211 produced…
Today (16 April) i-design released a positive FY12 half-year end trading update. Revenues are expected to be ahead of H111, benefiting from strong software…
Pacira Pharmaceuticals has launched its postsurgical analgesia treatment Exparel, triggering an imminent $10m launch milestone to SkyePharma. SkyePharma’s…
Endace’s year-end trading turned out somewhat better than anticipated in the March profit warning, while the settlement and release of debts owed…
Hitting a significant milestone in Q4 reinforces the central strategic thrust of raising group gross margins through a comprehensive and coherent business…
Spanish Mountain Gold’s expectations that the measured and indicated resources at the Main Zone will rise to 3Moz with 2.5Moz recoverable have been…
The proposal to acquire outstanding interests in the Netherlands effectively completes PPHE’s tidying of ownership issues, thereby allowing the company…
Topotarget’s partner, Spectrum Pharmaceuticals, is buying Allos Therapeutics to acquire a potential competitor to Topotarget’s belinostat for…
Ariana has released a number of positive announcements over recent months, signalling the steady progress of its Red Rabbit JV (first production due mid…
XP reported a 10% y-o-y decline in Q1 revenues, in line with our expectations. Stronger order intake in Q1 should support higher Q2 revenues, in line with…